Latest Ratios: P/E Ratio -0.0x · EV/EBITDA N/A · ROE -43.9%. (1997–2024 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $304032 | $5M | $29M | $38M | $90M | $21M | $35M | $29M | $23M | $23M | $37M |
| Enterprise Value | $573029 | $5M | $21M | $26M | $73M | $9M | $22M | $24M | $16M | $12M | $32M |
| P/E Ratio → | -0.02 | — | — | 16.05 | 7.10 | — | 15.80 | — | — | — | — |
| P/S Ratio | 0.01 | 0.24 | 0.97 | 0.89 | 2.30 | 0.72 | 1.08 | 1.06 | 0.79 | 0.74 | 1.46 |
| P/B Ratio | 0.01 | 0.20 | 0.73 | 0.64 | 1.62 | 0.50 | 0.76 | 0.83 | 0.66 | 0.62 | 0.91 |
| P/FCF | — | — | — | — | 15.04 | — | 71.15 | — | 12.92 | 20.89 | 26.04 |
| P/OCF | — | — | — | 66.73 | 13.92 | 83.91 | 38.11 | — | 10.42 | 14.58 | 18.35 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.25 | 0.72 | 0.61 | 1.86 | 0.32 | 0.70 | 0.89 | 0.53 | 0.38 | 1.25 |
| EV / EBITDA | — | — | — | 7.83 | 12.01 | — | 8.18 | — | — | — | — |
| EV / EBIT | — | — | — | 9.13 | 11.25 | — | 9.87 | — | — | — | — |
| EV / FCF | — | — | — | — | 12.18 | — | 45.76 | — | 8.75 | 10.74 | 22.38 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.6% | 23.6% | 15.8% | 47.0% | 47.0% | 27.4% | 46.2% | 42.8% | 30.1% | 33.2% | 29.7% |
| Operating Margin | -66.5% | -66.5% | -46.7% | 6.7% | 14.0% | -21.6% | 7.0% | -2.3% | -13.5% | -31.0% | -35.3% |
| Net Profit Margin | -65.4% | -65.4% | -65.4% | 5.5% | 32.7% | -21.1% | 7.1% | -1.7% | -15.5% | -31.1% | -51.1% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -43.9% | -43.9% | -39.4% | 4.1% | 26.4% | -14.1% | 5.6% | -1.3% | -12.6% | -24.6% | -26.5% |
| ROA | -32.0% | -32.0% | -33.2% | 3.5% | 22.5% | -12.3% | 4.9% | -1.1% | -11.0% | -21.5% | -23.9% |
| ROIC | -37.7% | -37.7% | -26.3% | 5.0% | 12.1% | -15.0% | 5.4% | -1.6% | -11.1% | -23.3% | -14.9% |
| ROCE | -42.5% | -42.5% | -26.8% | 4.7% | 10.8% | -14.2% | 5.5% | -1.7% | -10.7% | -23.8% | -18.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.17 | 0.17 | 0.07 | 0.06 | 0.07 | 0.06 | — | — | — | — | — |
| Debt / EBITDA | — | — | — | 1.10 | 0.69 | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.01 | -0.19 | -0.20 | -0.31 | -0.28 | -0.27 | -0.13 | -0.21 | -0.30 | -0.13 |
| Net Debt / EBITDA | — | — | — | -3.57 | -2.82 | — | -4.54 | — | — | — | — |
| Debt / FCF | — | — | — | — | -2.86 | — | -25.39 | — | -4.17 | -10.16 | -3.66 |
| Interest Coverage | -253.06 | -253.06 | — | — | 615.21 | -7144.49 | 1030.74 | -1124.85 | -2266.45 | -921.91 | -10037.98 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.33 | 1.33 | 3.48 | 5.27 | 6.36 | 3.69 | 5.93 | 3.70 | 4.49 | 6.07 | 4.98 |
| Quick Ratio | 0.80 | 0.80 | 2.42 | 3.65 | 4.32 | 2.54 | 3.40 | 1.64 | 2.37 | 3.55 | 2.20 |
| Cash Ratio | 0.29 | 0.29 | 1.48 | 2.30 | 3.79 | 2.16 | 2.65 | 0.84 | 1.61 | 2.77 | 1.09 |
| Asset Turnover | — | 0.54 | 0.61 | 0.62 | 0.60 | 0.60 | 0.63 | 0.66 | 0.72 | 0.74 | 0.54 |
| Inventory Turnover | 2.23 | 2.23 | 3.37 | 2.07 | 1.82 | 2.85 | 1.46 | 1.38 | 2.09 | 2.03 | 1.34 |
| Days Sales Outstanding | — | 18.20 | 7.68 | 20.93 | 17.79 | 8.39 | 22.21 | 45.60 | 34.97 | 26.44 | 63.52 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 6.2% | 14.1% | — | 6.3% | — | — | — | — |
| FCF Yield | — | — | — | — | 6.6% | — | 1.4% | — | 7.7% | 4.8% | 3.8% |
| Buyback Yield | 0.0% | 0.0% | 1.6% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 1.6% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M |
Liquidity and existential obsolescence
As reported in recent financial statements, CTHR's gross margins have compressed from 41.4% in 2023Q2 to 23.0% in 2025Q3, illustrating a profound loss of pricing power as the company struggles to differentiate its moissanite offerings from cheaper, lab-grown diamond alternatives in a saturated bridge luxury market.
The persistent negative operating margins, which reached -48.6% in the most recent quarter, suggest that the company's current revenue scale is fundamentally insufficient to absorb its fixed corporate and marketing overhead. Investors should monitor whether the shift toward the 'Caydia' brand can stabilize these margins or if the company remains trapped in a cycle of aggressive discounting to move stagnant inventory.
Based on the company's reported figures, the cash conversion cycle has become increasingly erratic, with inventory turnover metrics revealing that the firm is holding finished goods for extended periods, as evidenced by a DIO that reached 697 days in 2025Q3 compared to 258 days in 2023Q4.
The inability to efficiently convert inventory into cash, combined with a high reliance on accounts payable to manage liquidity, suggests significant operational friction. This trend warrants further investigation into whether the company's inventory valuation remains accurate or if future write-downs are required to reflect the declining market value of synthetic gemstones.
According to recent quarterly filings, the current ratio has declined to 0.95 as of 2025Q3, down from 5.00 in 2023Q3, indicating a rapidly narrowing liquidity buffer that leaves the firm with minimal protection against further operational shocks or the need for additional external financing.
The quick ratio of 0.33 highlights a heavy dependence on inventory liquidation to meet short-term obligations, which is particularly concerning given the current market environment for lab-grown stones. This liquidity profile suggests that the company may soon face a binary outcome regarding its ability to continue as a going concern without dilutive capital raises.
The market's reliance on P/S multiples to value CTHR is fundamentally flawed, as it obscures the company's structural inability to achieve operating breakeven and ignores the existential risk posed by the convergence of moissanite and lab-grown diamond prices in the consumer discretionary space.
Investors should instead focus on the cash burn rate relative to the remaining liquidity runway, as traditional valuation metrics like P/S fail to account for the potential for total equity impairment. The company is better viewed as a distressed asset in a declining category rather than a growth-oriented luxury retailer, making standard retail valuation benchmarks largely irrelevant.
Includes 30+ ratios · 28 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CTHR stock.
Charles & Colvard, Ltd.'s current P/E ratio is -0.0x. The historical average is 75.1x.
Charles & Colvard, Ltd.'s return on equity (ROE) is -43.9%. The historical average is -6.6%.
Based on historical data, Charles & Colvard, Ltd. is trading at a P/E of -0.0x. Compare with industry peers and growth rates for a complete picture.
Charles & Colvard, Ltd. has 23.6% gross margin and -66.5% operating margin.